Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04565821 · ClinicalTrials.gov registry record · NA

Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe

A NA study of Crohn Disease and Inflammatory Bowel Diseases, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04565821 is a NA study of Crohn Disease and Inflammatory Bowel Diseases that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 15 participants, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04565821, a NA study of Crohn Disease and Inflammatory Bowel Diseases, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the feasibility of using a trans-nasal IPD probe as a measurement tool for gut permeability

Interventions

  • DEVICE IPD Probe via TNIT

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2020-11-12
Est. Completion 2028-04-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04565821

The ClinicalTrials.gov registry entry for NCT04565821 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (93% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Crohn Disease appearing as the primary indexed condition, and to 1 intervention - of which IPD Probe via TNIT is the first listed.

NCT04565821 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04565821 about?

NCT04565821 is a clinical study titled "Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe". The purpose of this study is to examine the feasibility of using a trans-nasal IPD probe as a measurement tool for gut permeability

What is the current status of trial NCT04565821?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2020-11-12. Estimated completion is 2028-04-30.

What conditions does trial NCT04565821 study?

This clinical trial studies the following conditions: Crohn Disease, Inflammatory Bowel Diseases, Inflammatory Disease, Permeability; Increased, Environmental Enteropathy.

What interventions are being tested in trial NCT04565821?

The interventions under investigation include: IPD Probe via TNIT (DEVICE).

Who is sponsoring clinical trial NCT04565821?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04565821 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Crohn Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.